Author: Stock Hide Out

Chart Scan – Nov 09, 2022

Chart Scan – Nov 09, 2022

CLNE – Clean Energy Fuels Corp.

CRBU – Caribou Biosciences Inc.

FAZE – FaZe Holdings Inc.

HSTO – Histogen Inc.

INO – Inovio Pharmaceuticals, Inc.

KALA – Kala Pharmaceuticals, Inc.

OSUR – OraSure Technologies, Inc.

PACB – Pacific Biosciences of California Inc.

PSHG – Performance Shipping Inc.

PTE – PolarityTE, Inc.

RADI – Radius Global Infrastructure Inc.

SPRY – ARS Pharmaceuticals, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 09, 2022

Chart Scan – Nov 09, 2022

ABST – Absolute Software Corp.

ADMA – ADMA Biologics, Inc.

ADN – Advent Technologies Holdings, Inc.

AGRX – Agile Therapeutics Inc.

ALEC – Alector Inc.

ALLO – Allogene Therapeutics, Inc.

AMRS – Amyris Inc.

AMTX – Aemetis, Inc.

AVIR – Atea Pharmaceuticals Inc.

BBBY – Bed Bath & Beyond, Inc.

BBIO – BridgeBio Pharma Inc.

BLDP – Ballard Power Systems, Inc.

BRQS – Borqs Technologies Inc.

BTBT – Bit Digital Inc.

BXRX – Baudax Bio Inc.

CAN – Canaan Inc

CEMI – Chembio Diagnostics Inc.

CENN – Cenntro Electric Group Ltd.

CFMS – Conformis, Inc.

CHRS – Coherus BioSciences Inc.

CLSK – CleanSpark, Inc.

CLVS – Clovis Oncology, Inc.

COCO – Vita Coco Company Inc.

CRKN – Crown ElectroKinetics Corp.

CSTE – Caesarstone Ltd.

ELBM – Electra Battery Materials Corp.

EOLS – Evolus Inc.

FUV – Arcimoto, Inc.

GDRX – GoodRx Holdings, Inc.

GEVO – Gevo Inc.

GMBL – Esports Entertainment Group Inc.

GOEV – Canoo Inc.

GREE – Greenidge Generation Holdings, Inc.

HOOD – Robinhood Markets Inc.

HRTX – Heron Therapeutics, Inc.

IBRX – ImmunityBio, Inc.

IKNX – Ikonics Corp.

ILPT – Industrial Logistics Properties Trust

IMGN – ImmunoGen, Inc.

INFI – Infinity Pharmaceuticals, Inc.

IOVA – Iovance Biotherapeutics, Inc.

LFST – LifeStance Health Group Inc.

LOTZ – CarLotz, Inc.

LYEL – Lyell Immunopharma Inc.

ME – 23andMe Holding Co.

MGNI – Magnite, Inc

MQ – Marqeta Inc.

MRSN – Mersana Therapeutics, Inc.

MTTR – Matterport, Inc.

NBSE – NeuBase Therapeutics Inc.

NKLA – Nikola Corporation

OCGN – Ocugen Inc.

OMER – Omeros Corp.

OPK – Opko Health Inc.

PALI – Palisade Bio, Inc.

PCT – PureCycle Technologies Inc

PGEN – Precigen, Inc.

PLBY – PLBY Group, Inc.

PRCH – Porch.com, Inc.

PTRS – Partners Bancorp

QRTEA – Qurate Retail, Inc.

RDFN – Redfin Corp

RENT – Rent the Runway Inc.

RGTI – Rigetti Computing, Inc.

SDIG – Stronghold Digital Mining Inc.

SEV – Sono Group N.V.

SFT – Shift Technologies, Inc.

SKIN – The Beauty Health Company

SUNW – Sunworks, Inc.

SYTA – Siyata Mobile Inc.

TARK – AXS 2X Innovation ETF

TBLT – ToughBuilt Industries, Inc.

TCRT – Alaunos Therapeutics, Inc.

TDUP – ThredUp Inc.

TLS – Telos Corp.

TRVN – Trevena, Inc.

VBIV – VBI Vaccines Inc.

VERI – Veritone, Inc.

VUZI – Vuzix Corp.

WETG – WeTrade Group

WIMI – Wimi Hologram Cloud Inc

WISH – ContextLogic Inc.

WPRT – Westport Fuel Systems Inc.

WULF – TeraWulf Inc.

WW – Weight Watchers Intl Inc.

XAIR – Beyond Air Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 09, 2022

Chart Scan – Nov 09, 2022

CANO – Cano Health, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 09, 2022

Chart Scan – Nov 09, 2022

KALA – Kala Pharmaceuticals, Inc.

OLPX – Olaplex Holdings Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 08, 2022

Chart Scan – Nov 08, 2022

ARKO – ARKO Corp.

BGCP – BGC Partners, Inc.

CERS – Cerus Corp.

CGNT – Cognyte Software Ltd.

FTCI – FTC Solar Inc.

GRPN – Groupon Inc.

HIMX – Himax Technologies Inc.

ICCM – Icecure Medical Ltd.

IMPP – Imperial Petroleum Inc.

LILAK – Liberty LiLAC Group, Inc.

NCMI – National CineMedia Inc.

NVTS – Navitas Semiconductor Corporation

OCUP – Ocuphire Pharma, Inc.

OPRT – Oportun Financial Corp.

PRPL – Purple Innovation, Inc.

ROVR – Rover Group Inc.

TCMD – Tactile Systems Technology Inc.

TNXP – Tonix Pharmaceuticals Holding Corp.

VORB – Virgin Orbit Holdings, Inc.

VVPR – VivoPower International PLC

TEVA – Teva Pharmaceutical Industries Ltd.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 08, 2022

Chart Scan – Nov 08, 2022

AEI – Alset EHome International Inc.

AGEN – Agenus Inc.

ALRN – Aileron Therapeutics Inc.

ALTO – Alto Ingredients Inc

ARDX – Ardelyx, Inc.

ATHX – Athersys, Inc.

BIRD – Allbirds Inc.

BITF – Bitfarms Ltd.

BTF – Valkyrie Bitcoin Strategy ETF

BVS – Bioventus Inc.

CFRX – ContraFect Corp.

CLOV – Clover Health Investments Corp.

DBGI – Digital Brands Group Inc.

ECOR – electroCore, Inc.

EOSE – Eos Energy Enterprises, Inc.

EVGO – EVgo Inc.

FSRD – Fast Radius Inc.

GFAI – Guardforce AI Co Ltd.

IHRT – iHeartMedia Inc.

INSG – Inseego Corp.

LTRPA – Liberty TripAdvisor Holdings, Inc.

MAPS – WM Technology, Inc.

NSTG – NanoString Technologies, Inc.

OCUL – Ocular Therapeutix Inc.

PLTK – Playtika Holding Corp.

PRTS – CarParts.com

REE – REE Automotive Ltd

SWVL – Swvl Holdings Corp

VFF – Village Farms International, Inc.

VLDR – Velodyne Lidar, Inc.

WISA – Summit Wireless Technologies, Inc.

ZVO – Zovio Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 08, 2022

Chart Scan – Nov 08, 2022

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 08, 2022

Chart Scan – Nov 08, 2022

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 07, 2022

Chart Scan – Nov 07, 2022

ACMR – ACM Research, Inc.

ALLK – Allakos Inc.

ANNX – Annexon Inc.

ARHS – Arhaus Inc.

CD – Chindata Group Holdings Ltd.

CFFN – Capitol Federal Financial

CVT – Cvent Holding Corp.

DGLY – Digital Ally Inc.

DSEY – Diversey Holdings Ltd.

DWACW – Digital World Acquisition Corp.

DXLG – Destination XL Group, Inc.

GCT – GigaCloud Technology Inc.

GNUS – Genius Brands International, Inc.

IMGN – ImmunoGen, Inc.

JWEL – Jowell Global Ltd.

ONCY – Oncolytics Biotech, Inc.

PSEC – Prospect Capital Corp.

SDC – SmileDirectClub Inc.

SIGA – SIGA Technologies, Inc.

SIRI – Sirius XM Holdings Inc.

SLS – SELLAS Life Sciences Group, Inc.

UROY – Uranium Royalty Corp.

VLDR – Velodyne Lidar, Inc.

WW – Weight Watchers Intl Inc.

XXII – 22nd Century Group, Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Chart Scan – Nov 07, 2022

Chart Scan – Nov 07, 2022

ALLO – Allogene Therapeutics, Inc.

ARVL – Arrival Ltd.

AUR – Aurora Innovation, Inc.

BBIO – BridgeBio Pharma Inc.

CNCE – Concert Pharmaceuticals, Inc.

HIVE – HIVE Blockchain Technologies Ltd.

IKT – Inhibikase Therapeutics Inc.

IOVA – Iovance Biotherapeutics, Inc.

JWEL – Jowell Global Ltd.

KERN – Akerna Corp.

LPRO – Open Lending Corp

MEIP – MEI Pharma, Inc.

NEGG – Newegg Commerce, Inc.

RDFN – Redfin Corp

RUBY – Rubius Therapeutics, Inc.

SANA – Sana Biotechnology Inc.

VXRT – Vaxart, Inc.

WISH – ContextLogic Inc.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.

Disclaimer:
We have not received any form of compensation for the generation of this blog

Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.

Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be compensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.

We are not held liable or responsible for the information in press releases issued by the companies discussed in these blog. Please do your own due diligence.